Publications | Beyond Air Inc. (XAIR)

Contact

Antibacterial Activity of High-dose Nitric Oxide against Pulmonary Mycobacterium abscessus Disease
Bogdanovskia, K. et al. (2019) • Manuscript submitted, in progress
Synergistic Effect of Nitric Oxide with Antibiotics Against Mycobacterium Abscessus in Vitro. American Journal of Respiratory and Critical Care Medicine; 199:A2656
Chau, T., et al. (2019) • January 2019
A phase-III multicenter, randomized, double-blind, controlled trial of high-dose inhaled nitric oxide in infants with acute bronchiolitis. European Respiratory Journal 52: PA4642.
Goldbart, A., et al. (2018) • November 19, 2018
Nitric oxide inhalation in CF patients infected with Mycobacterium Abscessus complex: A prospective, open-labeled, multi-center pilot study. American Journal of Respiratory and Critical Care Medicine 2018;197:A5919
Bentur L., et al. (2018) • October 2018
High-dose inhaled nitric oxide as a potential therapy against mycobacterium abscessus lung infection in cystic fibrosis. Pediatric Pulmonology, 52(S2): S1-S481
Bogdanovski K., et al. (2018) • October 18-20, 2018
High-Dose Inhaled Nitric Oxide as a Potential Therapy Against Mycobacterium Abscessus Lung Infection in Cystic Fibrosis. 3rd World Bronchiectasis Conference, Chronic Obstr Pulm Dis. 2018; 5(4): 302-323.
Bogdanovski K., et al. (2018) • October 2018
High-dose nitric oxide as a potential new therapeutic agent against Mycobacterium abscessus. European Respiratory Journal 52: Suppl. 62, PA5463.
Ghaffari, A. et al. (2018) • September 15, 2018
High-dose Nitric Oxide inhibits growth of Mycobacterium Abscessus. ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance, Lisbon, Portugal. (available in print only)
Bogdanovski K., et al. (2018) • Sept 4-7, 2018
Treatment of refractory mycobacterium abscessus lung infection with inhaled intermittent nitric oxide. 3rd World Bronchiectasis Conference, Chronic Obstr Pulm Dis. 2018; 5(4): 302-323.
Olivier K.N., et al. (2018) • September 2018
On-Demand Nitric Oxide for Ventilator-Based Nitric Oxide Inhalation: A Risk-Reduction Perspective. The International Society for Aerosols in Medicine, Montreux, Switzerland.
Rimkus M., et al. (2019) • May 25-29, 2018